Role of Prophylactic Oxytocin in the Third Stage of Labor: Physiologic Versus Pharmacologically Influenced Labor and Birth

Elise N. Erickson, Christopher Lee, Cathy Emeis

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Introduction: Maternity care providers administer oxytocin prophylactically to prevent postpartum hemorrhage (PPH). Prophylactic oxytocin is generally considered effective and safe and is promoted by national organizations for standardized use. In this article, the evidence supporting prophylactic oxytocin administration for women undergoing spontaneous labor and birth compared with women whose labors included administration of exogenous oxytocin for induction or augmentation is explored. Methods: Using data from randomized controlled trials included in 2 recent Cochrane meta-analyses papers, only studies with women in spontaneous labor were selected for inclusion (N = 4 studies). Outcomes of immediate postpartum bleeding volumes (≥ 500 mL or 1000 mL), risk for blood transfusion, and risk for administration of more uterotonic medication were pooled from these 4 studies. Focused random effects meta-analytics were used. Results: Compared to women without prophylactic oxytocin, women who received prophylactic oxytocin had a lower risk of having a 500 mL or higher blood loss. However, prophylactic oxytocin did not lower risk of PPH (≥ 1000 mL), blood transfusion, or need for additional uterotonic treatment. Discussion: Prophylactic oxytocin may not confer the same benefits to women undergoing spontaneous labor and birth compared to women laboring with oxytocin infusion. Reasons for this difference are explored from a pharmacologic perspective. In addition, the value of prophylactic oxytocin given recent changes in the definition of PPH from greater than or equal to 500 mL to 1000 mL or more after birth is discussed. Finally, gaps in research on adverse effects of prophylactic oxytocin are presented. More research is needed on reducing risk of PPH for women in spontaneous labor.

Original languageEnglish (US)
Pages (from-to)418-424
Number of pages7
JournalJournal of Midwifery and Women's Health
Volume62
Issue number4
DOIs
StatePublished - Jul 1 2017

Fingerprint

Third Labor Stage
Oxytocin
Parturition
Postpartum Hemorrhage
Blood Transfusion
Postpartum Period
Research
Meta-Analysis

Keywords

  • active management third stage labor
  • adverse drug effects
  • oxytocin
  • postpartum hemorrhage
  • third stage of labor

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Maternity and Midwifery

Cite this

Role of Prophylactic Oxytocin in the Third Stage of Labor : Physiologic Versus Pharmacologically Influenced Labor and Birth. / Erickson, Elise N.; Lee, Christopher; Emeis, Cathy.

In: Journal of Midwifery and Women's Health, Vol. 62, No. 4, 01.07.2017, p. 418-424.

Research output: Contribution to journalReview article

@article{0c191774f78940f8a422a4e7e2cbbb70,
title = "Role of Prophylactic Oxytocin in the Third Stage of Labor: Physiologic Versus Pharmacologically Influenced Labor and Birth",
abstract = "Introduction: Maternity care providers administer oxytocin prophylactically to prevent postpartum hemorrhage (PPH). Prophylactic oxytocin is generally considered effective and safe and is promoted by national organizations for standardized use. In this article, the evidence supporting prophylactic oxytocin administration for women undergoing spontaneous labor and birth compared with women whose labors included administration of exogenous oxytocin for induction or augmentation is explored. Methods: Using data from randomized controlled trials included in 2 recent Cochrane meta-analyses papers, only studies with women in spontaneous labor were selected for inclusion (N = 4 studies). Outcomes of immediate postpartum bleeding volumes (≥ 500 mL or 1000 mL), risk for blood transfusion, and risk for administration of more uterotonic medication were pooled from these 4 studies. Focused random effects meta-analytics were used. Results: Compared to women without prophylactic oxytocin, women who received prophylactic oxytocin had a lower risk of having a 500 mL or higher blood loss. However, prophylactic oxytocin did not lower risk of PPH (≥ 1000 mL), blood transfusion, or need for additional uterotonic treatment. Discussion: Prophylactic oxytocin may not confer the same benefits to women undergoing spontaneous labor and birth compared to women laboring with oxytocin infusion. Reasons for this difference are explored from a pharmacologic perspective. In addition, the value of prophylactic oxytocin given recent changes in the definition of PPH from greater than or equal to 500 mL to 1000 mL or more after birth is discussed. Finally, gaps in research on adverse effects of prophylactic oxytocin are presented. More research is needed on reducing risk of PPH for women in spontaneous labor.",
keywords = "active management third stage labor, adverse drug effects, oxytocin, postpartum hemorrhage, third stage of labor",
author = "Erickson, {Elise N.} and Christopher Lee and Cathy Emeis",
year = "2017",
month = "7",
day = "1",
doi = "10.1111/jmwh.12620",
language = "English (US)",
volume = "62",
pages = "418--424",
journal = "Journal of Midwifery and Women's Health",
issn = "1526-9523",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Role of Prophylactic Oxytocin in the Third Stage of Labor

T2 - Physiologic Versus Pharmacologically Influenced Labor and Birth

AU - Erickson, Elise N.

AU - Lee, Christopher

AU - Emeis, Cathy

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Introduction: Maternity care providers administer oxytocin prophylactically to prevent postpartum hemorrhage (PPH). Prophylactic oxytocin is generally considered effective and safe and is promoted by national organizations for standardized use. In this article, the evidence supporting prophylactic oxytocin administration for women undergoing spontaneous labor and birth compared with women whose labors included administration of exogenous oxytocin for induction or augmentation is explored. Methods: Using data from randomized controlled trials included in 2 recent Cochrane meta-analyses papers, only studies with women in spontaneous labor were selected for inclusion (N = 4 studies). Outcomes of immediate postpartum bleeding volumes (≥ 500 mL or 1000 mL), risk for blood transfusion, and risk for administration of more uterotonic medication were pooled from these 4 studies. Focused random effects meta-analytics were used. Results: Compared to women without prophylactic oxytocin, women who received prophylactic oxytocin had a lower risk of having a 500 mL or higher blood loss. However, prophylactic oxytocin did not lower risk of PPH (≥ 1000 mL), blood transfusion, or need for additional uterotonic treatment. Discussion: Prophylactic oxytocin may not confer the same benefits to women undergoing spontaneous labor and birth compared to women laboring with oxytocin infusion. Reasons for this difference are explored from a pharmacologic perspective. In addition, the value of prophylactic oxytocin given recent changes in the definition of PPH from greater than or equal to 500 mL to 1000 mL or more after birth is discussed. Finally, gaps in research on adverse effects of prophylactic oxytocin are presented. More research is needed on reducing risk of PPH for women in spontaneous labor.

AB - Introduction: Maternity care providers administer oxytocin prophylactically to prevent postpartum hemorrhage (PPH). Prophylactic oxytocin is generally considered effective and safe and is promoted by national organizations for standardized use. In this article, the evidence supporting prophylactic oxytocin administration for women undergoing spontaneous labor and birth compared with women whose labors included administration of exogenous oxytocin for induction or augmentation is explored. Methods: Using data from randomized controlled trials included in 2 recent Cochrane meta-analyses papers, only studies with women in spontaneous labor were selected for inclusion (N = 4 studies). Outcomes of immediate postpartum bleeding volumes (≥ 500 mL or 1000 mL), risk for blood transfusion, and risk for administration of more uterotonic medication were pooled from these 4 studies. Focused random effects meta-analytics were used. Results: Compared to women without prophylactic oxytocin, women who received prophylactic oxytocin had a lower risk of having a 500 mL or higher blood loss. However, prophylactic oxytocin did not lower risk of PPH (≥ 1000 mL), blood transfusion, or need for additional uterotonic treatment. Discussion: Prophylactic oxytocin may not confer the same benefits to women undergoing spontaneous labor and birth compared to women laboring with oxytocin infusion. Reasons for this difference are explored from a pharmacologic perspective. In addition, the value of prophylactic oxytocin given recent changes in the definition of PPH from greater than or equal to 500 mL to 1000 mL or more after birth is discussed. Finally, gaps in research on adverse effects of prophylactic oxytocin are presented. More research is needed on reducing risk of PPH for women in spontaneous labor.

KW - active management third stage labor

KW - adverse drug effects

KW - oxytocin

KW - postpartum hemorrhage

KW - third stage of labor

UR - http://www.scopus.com/inward/record.url?scp=85026661898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026661898&partnerID=8YFLogxK

U2 - 10.1111/jmwh.12620

DO - 10.1111/jmwh.12620

M3 - Review article

C2 - 28703925

AN - SCOPUS:85026661898

VL - 62

SP - 418

EP - 424

JO - Journal of Midwifery and Women's Health

JF - Journal of Midwifery and Women's Health

SN - 1526-9523

IS - 4

ER -